Sakar Healthcare Limited (NSE:SAKAR)
823.90
+23.55 (2.94%)
Jul 10, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 18.35 billion as of July 10, 2026. Its market cap has increased by 138.03% in one year.
Market Cap
18.35B
Enterprise Value
19.05B
Revenue
2.52B
Ranking
n/a
PE Ratio
60.18
Stock Price
823.90
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 18.35B, an increase of 3,175.27%. That is a compound annual growth rate of 48.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 18.35B | 101.49% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.73B |
| Innova Captab | 56.70B |
| Orchid Pharma | 53.30B |
| RPG Life Sciences | 43.94B |
| Solara Active Pharma Sciences | 27.31B |
| Indoco Remedies | 23.55B |
| Beta Drugs | 22.11B |
| Ind-Swift Laboratories | 20.43B |